its chronic not acute..im sure a few posters here will highlight perfectly the difference!
Sanofi paid 1.9.bill usd for Kadmons Rezurock..first in class treatment for chronic GVHD.
Our IND for aGVHD, i.e second generation, one time only donor, excellent phase 1 results, no WTF is in this concotion this time around scenario!!..should get us some serious attention...
Thats just cyp 001...Acorns and Oak trees and all that!!
cyp 002 Cli
cyp..oo4 OA knee.
cyp ??..cypatch
But we need less non execs and more full timers..especially a spat wearing go getting salesmen!!
justa bit more research for me..but im getting there!!
- Forums
- ASX - By Stock
- CYP
- 1.9 billion for chronic gvhd acquisition
CYP
cynata therapeutics limited
Add to My Watchlist
0.00%
!
16.5¢

1.9 billion for chronic gvhd acquisition
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.0¢ | $29.18K | 176.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66467 | 0.160 |
4 | 181490 | 0.155 |
5 | 318045 | 0.150 |
4 | 81775 | 0.145 |
4 | 307863 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 65000 | 1 |
0.185 | 35419 | 2 |
0.190 | 114978 | 3 |
0.195 | 5764 | 1 |
0.200 | 55400 | 2 |
Last trade - 15.59pm 25/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online